Treace Medical Concepts, Inc.
TMCI
$6.51
-$0.21-3.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3,078.04% | 96.74% | 27.57% | -13.55% | -197.34% |
| Total Depreciation and Amortization | 98.95% | -42.65% | 1.94% | 10.84% | 50.43% |
| Total Amortization of Deferred Charges | -93.12% | 1,352.70% | 0.00% | -1.33% | -86.93% |
| Total Other Non-Cash Items | -10.12% | 50.87% | -19.90% | 14.95% | 22.02% |
| Change in Net Operating Assets | 145.29% | -183.53% | -50.83% | -355.49% | 202.70% |
| Cash from Operations | 199.79% | 64.47% | 14.79% | -92.45% | -1,457.33% |
| Capital Expenditure | -15.26% | -7.37% | -65.59% | 55.97% | -74.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -74.61% | -24.70% | -64.30% | 214.40% | 5.93% |
| Cash from Investing | -155.36% | -40.64% | -74.31% | 496.94% | -24.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 108.77% | 612.50% | -97.43% | 498.08% | -70.79% |
| Repurchase of Common Stock | -1,193.55% | -- | -- | 100.00% | -1,723.08% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,184.62% | 225.00% | -97.43% | 268.11% | -212.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 366.05% | 87.48% | -168.62% | 342.52% | -163.96% |